Verona Pharma Plc Profit Margin

Verona Pharma Plc (VRNA) currently reports a profit margin of -36.62% as of June 2025. That compares with -13356.25% in the prior-year period — up 99.7% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Verona Pharma Plc's profit margin history and peer comparisons.

Verona Pharma Plc's profit margin increased from -13356.25% to -36.62% — a 99.7% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Verona Pharma Plc's profit margin of -36.62% is lower than the Healthcare sector average of 21.34%. That is roughly 271.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Verona Pharma Plc's current -36.62% should be judged against Healthcare norms (sector average: 21.34%) and against VRNA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -36.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Verona Pharma Plc, and consider following VRNA for alerts when major investors trade the stock.